Health Canada
Symbol of the Government of Canada
About Health Canada

Access to Information Requests Completed - January 2011

Warning This content was archived on June 24, 2013.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

AER
Adverse Reaction Report (Adverse Event)
DIN
Drug Identification Number
MRL
Maximum Residue Level
NPN
Natural Product Number
SAP
Special Authorization Program

Completed Requests

For the month of January 2011
Request # Request text summary Status of Completed Request
A-2008-00232 Information regarding "Drogues : savoir plus, risquer moins" [Drugs: More Knowledge, Less Risk]. Disclosed in part
A-2008-00566 Information regarding Janssen-Ortho Inc.'s application for approval to market EVRA (Contraceptive Patch), approved by Health Canada in August 2002. Disclosed in part
A-2008-00778 Information regarding listenia/listeriosis.  (Mar 1, 2008 to Sep 30, 2008). Disclosed in part
A-2008-00872 Information regarding January 2008 records dealing with non-occupational exposure to asbestos products. Disclosed in part
A-2009-00405 Information regarding the product DDS Plus, NPN 80010531 by Inno-vite. Disclosed in part
A-2009-00563 Information regarding the product Advil Allergy Sinus Caplets (Chlorpheniramine Maleate, Ibuprofin, Pseudoephredine Hydrochloride), DIN: 02248645 by Wyeth Consumer Healthcare Inc. All exempted
A-2009-00600 All records from the face-to-face meetings of the Consumer Product Safety National Toy Committee. (Sep 1, 2008 to Jul 31, 2009). Disclosed in part
A-2009-00728 Information regarding the products BioGlue Surgical Adhesive or BioGlue. (Jan 1, 2000 to Jun 1, 2009). Disclosed in part
A-2009-00774 Copies of the most recent reports of inspections carried out and sanctions imposed by Health Canada in manufacturer Apotex's Canadian production factories. January 2007 to 25 September, 2009. Disclosed in part
A-2009-01098 All communications between GlaxoSmithKline (GSK) & Tim Vail, Scott Tessier and/or Deputy Minister Morris Rosenberg. (Sep 1 to Sep 30, 2009). Disclosed in part
A-2009-01161 Information regarding the approval of H1N1 Vaccine. (Mar 1, 2009 to Nov 24, 2009). Disclosed in part
A-2009-01266 Information regarding the product Rephresh Pro-B, NPN 80012146 by Lil'Drug Store Products Inc. Disclosed in part
A-2009-01383 Information regarding Pyrimethanil Technical Fungicide, Reg No. 28010, and Scala SC Fungicide, Reg No 28011.
Full dietary risk assessments by for the following submissions:
- H-96-0023:  Import MRL application for pyrimethanil on grapes
- 2001-2137:  Import MRL application for pyrimethanil on bananas
- 2003-1079/1080:  Domestic registration application for pyrimethanil and Scala SC Fungicide
- 2005-1050:  Import MRL application for pyrimethanil on onions and stonefruit
- 2005-4341:  Import MRL application for pyrimethanil on pistachios and almonds
- D.3.2: 2007-7850:  Domestic registration application for pyrimethanil on greenhouse tomatoes
- 2007-8746 - Import MRL application for pyrimethanil post-harvest uses on pome fruit
All disclosed
A-2009-01439 Information regarding the product Aor Niacin No-Flush, NPN 80015111 by Advanced Orthomolecular Research Inc. Disclosed in part
A-2009-01442 Information regarding the product Real Fibre, NPN 80009901. Disclosed in part
A-2010-00147 Information regarding the product Allergy, DIN 02320789 by ACCUDIAL INC. Disclosed in part
A-2010-00152 Information regarding the product Nite Time Cough & Cold, DIN 02323915 by ACCUDIAL INC. Disclosed in part
A-2010-00219 All documentation regarding serious and unexpected adverse drug reactions that have occurred during clinical trials at Algorithme Pharma from 2002 to present (May 26, 2010). Disclosed in part
A-2010-00318 Information regarding the Standing Offer. Reference Number 4500229326. (Mar 14, 2010 to Apr 12, 2010). Disclosed in part
A-2010-00319 Information regarding the Standing Offer. Reference Number 4500229327. (Mar 14, 2010 to Apr 12, 2010). Disclosed in part
A-2010-00380 Information regarding the product DIMETAPP EXTENTABS, DIN 01933604. Disclosed in part
A-2010-00386 Costs of immunization materials for combating the H1N1 virus in 2009/2010. Disclosed in part
A-2010-00399 AERs. Report numbers: 000332131, 000332133, 000331263, 000332135, 000332136, 000333403, 000335267, 000332132, 000333815 and 000335517. Disclosed in part
A-2010-00425 Information regarding the meeting held within the Medical Marihuana Access Division on June 28, 2010. Disclosed in part
A-2010-00634 Workplace Assessment of the Finance Department, Health Canada, Edmonton. (Aug 17, 2009 to Feb 19, 2010). Disclosed in part
A-2010-00655 AERs for the product AVELOX. Report numbers: 000316294, 000316493, 000316749, 000316999 and 000317430. Disclosed in part
A-2010-00694 Copy of contract No. HT226-071798/001/EJ, between Public Works and Government Services Canada (PWGSC) and Emperorlinux and awarded February 7, 2008 (and any amendments thereto). All disclosed
A-2010-00695 Copy of Contract No. HT226-081162/001/PY, between Public Works and Government Services Canada (PWGSC) and Emperorlinux and awarded November 21, 2008 (and any amendments thereto). All disclosed
A-2010-00696 Information regarding the Stakeholder information session on the Tobacco Reporting Information Regulations conducted by Health Canada officials in Montreal on or about October 24, 2000. Disclosed in part
A-2010-00709 AERs for the product Coversyl 8mg. Report numbers: 000319814 and 000325942. Disclosed in part
A-2010-00741 AERs for the product Aspirin. Report numbers: 000340946, 000342003 and 000342458. Disclosed in part
A-2010-00748 AERs. Report numbers: 000336199, 000337489, 000335965, 000336374, 000337006, 000337114, 000338089, 000339945, 000339954, 000339955 and 000340201. Disclosed in part
A-2010-00775 All communications between Mrs. Patricia (Pat) Todd and Mrs. Laurette Burch (Regional Director General of Manitoba). (Jan 1, 2009 to Oct 19, 2010). Disclosed in part
A-2010-00807 All docs prepared for Minister Leona Aglukkaq. (Jun 1, 2010 to Sep 30, 2010). Disclosed in part
A-2010-00884 Information regarding the product LAX-A-DAY (Polyethylene Glycol 3350), DIN 02317680 by PENDOPHARM, DIVISION OF PHARMASCIENCE INC. Disclosed in part
A-2010-00885 Information regarding the product RESTORALAX (Polyethylene Glycol 3350), DIN 02318164 by SCHERING-PLOUGH CANADA INC. Disclosed in part
A-2010-00892 AERs. Report numbers: 000341997, 000342667, 000343133, 000343333, 000346239, 000346647, 000343136, 000345760 and 000345828. Disclosed in part
A-2010-00951 All radon measurements collected during Phase 1 of the Cross Canada Residential Radon Survey Disclosed in part
A-2010-00952 A list of all Access to Information requests completed by Health Canada. (May 1, 2008 to Oct 31, 2010). Disclosed in part
A-2010-00955 Information regarding Novopharm/Teva Canada's generic atomoxetine drug submission. All exempted
A-2010-00956 Information regarding Apotex Inc.'s generic atomoxetine drug submission. All exempted
A-2010-00961 Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during November 2010. All disclosed
A-2010-00962 All Callups processed by this institution in the National Capital Region under the terms of any Standing Offer and/or Supply Arrangement for Temporary Help Services during November 2010. Disclosed in part
A-2010-00985 AERs for the products PANTOLOC (pantoprazole sodium) and TECTA (pantoprazole magnesium). Report numbers: 000347167, 000350670, 000347589 and 000350468. Disclosed in part
A-2010-00987 AER for the product POLLINEX-R. Report number: 000347964. Disclosed in part
A-2010-00992 Tobacco records previously disclosed under the Access to Information Act. Requests numbers: A-2006-00965, A-2007-00448, A-2007-00747, A-2007-00763, A-2008-00054, A-2008-00105, A-2009-01323, A-2010-00863 and A-2010-00864. Disclosed in part
A-2010-00996 Testing result records for the following products:
- Brazilian Keratin Treatment by Marcia Teixeira
- Advanced Brazilian Keratin Treatment by Marcia Teixeira
- Chocolate Extreme De-Frizzing Treatment by Marcia Teixeira
- Keratin Complex Smoothing Therapy by Coppola
- Global Keratin Taming System Strawberry by Global Keratin
- Global Keratin Taming System with Juvexin Strawberry Resistant by Global Keratin
- Global Keratin Taming System with Juvexin Strawberry Light Wave by Global Keratin
- Pro-Collagen RX Keratin Treatment
- iStraight Keratin (Advanced Keratin Treatment) by IBS Beauty
- Brazilian Thermal Reconstruction by Cadiveu
All disclosed
A-2010-00997 List of Access to Information requests submitted to Health Canada for November 2010. All disclosed
A-2010-01002 Information regarding the product Kalms, NPN 80015782 by G.R. Lane Health Products Limited. Disclosed in part
A-2010-01003 Information regarding the product Chlorophylle Liquide, Le Naturiste, Liquid Chlorophyll, NPN 80015472 by Vitaminol Inc. Disclosed in part
A-2010-01004 Information regarding the product Aquafresh White & Shine and Aquafresh White & Shine Berry Fresh, NPN 02240400. Disclosed in part
A-2010-01005 AER for the product PANTOLOC (pantoprazole sodium). Report number: 000341100. Disclosed in part
A-2010-01013 Number of SAPs for Dacogen (Decitabine) for the month of December 2010. All disclosed
A-2010-01017 Number of SAPs for Treanda (Bendamustine) for the month of December 2010. All disclosed
A-2010-01019 Number of SAPs for Cabazitaxel (Jevtana) for the month of December 2010. All disclosed